Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Onset Seizures”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Post-approval studies (Phase 4)Study completedNCT00288639
What this trial is testing

Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 98
Testing effectiveness (Phase 2)Study completedNCT00871377
What this trial is testing

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures

Who this might be right for
Epilepsy
National Center for Complementary and Integrative Health (NCCIH) 24
Large-scale testing (Phase 3)Ended earlyNCT00524030
What this trial is testing

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 161
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00141258
What this trial is testing

Pregabalin Epilepsy Add-On Trial

Who this might be right for
Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 178
Large-scale testing (Phase 3)Study completedNCT05614063
What this trial is testing

Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Who this might be right for
Focal Onset Seizures
Xenon Pharmaceuticals Inc. 380
Testing effectiveness (Phase 2)Study completedNCT03780907
What this trial is testing

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

Who this might be right for
Epilepsy
Eisai Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Large-scale testing (Phase 3)Study completedNCT00957684
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Refractory Partial Epilepsy
Bial - Portela C S.A. 402
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Testing effectiveness (Phase 2)Study completedNCT00552305
What this trial is testing

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Who this might be right for
Partial Epilepsies
UCB Pharma 370
Testing effectiveness (Phase 2)Study completedNCT00034814
What this trial is testing

Multicenter Trial for Adults With Partial Seizures

Who this might be right for
Epilepsy
Teva Branded Pharmaceutical Products R&D, Inc. 190
Not applicableLooking for participantsNCT06265103
What this trial is testing

Epilepsy Learning Healthcare System (ELHS)

Who this might be right for
EpilepsySeizure DisorderNeurologic Disorder+1 more
Epilepsy Foundation of America 100,000
Large-scale testing (Phase 3)Looking for participantsNCT05135091
What this trial is testing

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Who this might be right for
Mesial Temporal Lobe Epilepsy
Neurona Therapeutics 88
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Large-scale testing (Phase 3)Study completedNCT00141336
What this trial is testing

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Who this might be right for
Seizure Disorder, Partial
Pfizer 750
Not applicableNot Yet RecruitingNCT07343609
What this trial is testing

Predictive Value of Seizure Frequency at Onset for Long-Term Seizure Control

Who this might be right for
Newly Diagnosed Epilepsy With Focus on Seizure Frequency at Onset and Long-term Seizure Control
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT05533814
What this trial is testing

Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Who this might be right for
Epilepsy
Eisai Korea Inc. 125
Load More Results